Incidence of Hepatocellular Carcinoma in Type 2 Diabetes with Cirrhosis Who Were Treated with Metformin

被引：0
|
作者：
Tangjarusritaratorn, Thanida
Kunavisarut, Tada
Tangjittipokin, Watip
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1605-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1605-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Type 2 diabetes mellitus is a risk factor for hepatocellular carcinoma in Egyptian patients with HCV-related cirrhosis
    El-Eshmawy, Mervat M.
    Kandil, Tharwat S.
    Abd El-Hafez, Hala A.
    Abo El Yazid, Ahmed Y.
    El Hadidy, El M.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2014, 34 (04) : 210 - 214
  • [42] Type 2 diabetes mellitus is a risk factor for hepatocellular carcinoma in Egyptian patients with HCV-related cirrhosis
    Mervat M. El-Eshmawy
    Tharwat S. Kandil
    Hala A. Abd El-Hafez
    Ahmed Y. Abo El yazid
    El Hadidy M. El Hadidy
    International Journal of Diabetes in Developing Countries, 2014, 34 : 210 - 214
  • [43] THE ENHANCED LIVER FIBROSIS TEST IS ASSOCIATED WITH DEVELOPMENT OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS
    Trembling, Paul M.
    Grecian, Sheila M.
    Strachan, Mark W. J.
    Rosenberg, William M.
    Fallowfield, Jonathan A.
    GUT, 2023, 72 : A53 - A53
  • [44] Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study
    Grecian, Sheila M.
    McLachlan, Stela
    Fallowfield, Jonathan A.
    Kearns, Patrick K. A.
    Hayes, Peter C.
    Guha, Neil, I
    Morling, Joanne R.
    Glancy, Stephen
    Williamson, Rachel M.
    Reynolds, Rebecca M.
    Frier, Brian M.
    Zammitt, Nicola N.
    Price, Jackie F.
    Strachan, Mark W. J.
    LIVER INTERNATIONAL, 2020, 40 (09) : 2252 - 2262
  • [45] Decrease the concentration of cobalamin in patients with type 2 diabetes treated with metformin
    Gauthier, C.
    Radu, A.
    Gonfroy, C.
    Rotariu, M.
    Saatdjian, L.
    Bernard, V.
    Boitard, C.
    Larger, E.
    DIABETES & METABOLISM, 2011, 37 : A34 - A35
  • [46] THE ENHANCED LIVER FIBROSIS TEST IS ASSOCIATED WITH DEVELOPMENT OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS
    Trembling, Paul M.
    Grecian, Sheila M.
    Strachan, Mark W. J.
    Rosenberg, William M.
    Fallowfield, Jonathan A.
    HEPATOLOGY, 2023, 78 : S1560 - S1561
  • [47] Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
    Li, Man-Yu
    Li, Ting-Ting
    Li, Ke-Jian
    Zhou, Cheng
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (05) : 1009 - 1018
  • [48] A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma
    Michel, Maurice
    Kalliga, Eva
    Labenz, Christian
    Straub, Beate K.
    Woerns, Marcus-Alexander
    Galle, Peter R.
    Schattenberg, Joern M.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (01): : 57 - 62
  • [49] Acute kidney injury in patients with Type 2 diabetes treated with metformin
    Bell, S.
    Farran, B.
    McGurnaghan, S.
    Colhoun, H.
    Looker, H.
    DIABETIC MEDICINE, 2016, 33 : 85 - 85
  • [50] Thymic emigration patterns in patients with type 2 diabetes treated with metformin
    Dworacki, Grzegorz
    Urazayev, Olzhas
    Bekmukhambetov, Yerbol
    Iskakova, Saule
    Frycz, Bartosz A.
    Jagodzinski, Pawel P.
    Dworacka, Marzena
    IMMUNOLOGY, 2015, 146 (03) : 456 - 469
12345